The whole market will likely see movement when Nvidia (NVDA) reports earnings on Wednesday. Its stock has closed the gap left by the DeepSeek sell-off, though recent stagnation kept its price near $140.
Nvidia (NVDA) is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.
The wide gap between the fair value of Nvidia Corporation's business and the current market cap can close soon, as I expect the company to deliver strong earnings on February 26. Several Wall Street analysts expect Nvidia to deliver another stellar quarter, with significant YOY revenue and EPS growth anticipated. Nvidia's valuation appears significantly undervalued; a fair 8% perpetual growth rate suggests a 34% upside potential.
Everyone knows that NVIDIA Co. NASDAQ: NVDA is the leader in the technology sector and its race to provide the necessary components for artificial intelligence to grow into what most investors think it could be. However, this doesn't mean that investors need to only pay attention to NVIDIA but rather zoom out into some of the other less crowded ideas out there.
Besides Wall Street's top -and-bottom-line estimates for Nvidia (NVDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended January 2025.
Nvidia (NASDAQ:NVDA) remains a top investment choice in 2025, driven by its dominance in AI, high-performance computing, and innovation across multiple industries.
The major chip stocks that I follow are somewhat ambivalent about the conditions of the market on Friday in premarket trading, as we see overall positive conditions, but are still looking for a catalyst.
Coming up just short of the 4% gain that the S&P 500 has enjoyed since the start of the year, Nvidia (NVDA 0.63%) has risen only about 3.4% in 2025. It may feel unfamiliar to see the artificial intelligence (AI) superstar in this position considering it soared 171% in 2024 while the S&P 500 ripped more than 23% higher.
NVIDIA's Q4 results are likely to reflect the benefits of strong demand for generative AI and LLM-supportive GPUs from data center operators.
Recursion Pharmaceuticals' NASDAQ: RXRX stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken by artificial intelligence (AI) chip giant NVIDIA NASDAQ: NVDA. A recent SEC filing showed NVIDIA reshuffling its AI investment portfolio, and while it trimmed its holdings in several AI ventures, it notably maintained its stake in Recursion Pharmaceuticals.
Nvidia Corp. (NASDAQ: NVDA) reports earnings on February 26, and one thing is almost a given across Wall Street: if they don't blow away expectations for revenue and profits and provide a very positive forward-looking forecast, we could be in for a big sell-off.
Artificial intelligence (AI) technology giant Nvidia (NVDA 0.63%) is slated to report its results for the fourth quarter of fiscal 2025 (ended Jan. 26) on Wednesday, Feb. 26, after the market close.